Two small cross-sectional studies have been conducted: one reported significantly lower AMH levels in 22 women diagnosed with cancer or precancerous lesions compared with 8 women with benign biopsies (McCoy et al. 2011), and the other one reported no significant difference in AMH levels between breast cancer cases and healthy controls (Su et al. 2013). The gene discussed is AMH; the disease is breast carcinoma.